Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

144.64 -5.89 (-3.91%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - MASI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Masimo Corporation (MASI)
From Law Offices of Howard G. Smith
Via Business Wire
MASIMO CORPORATION (NASDAQ: MASI) SHAREHOLDER ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Masimo Corporation
From Bernstein Liebhard LLP
Via GlobeNewswire
What 7 Analyst Ratings Have To Say About Masimo
 
Via Benzinga
Why Shares of Masimo Are Dropping Tuesday
The company's preliminary second-quarter numbers have investors worried. 
Via The Motley Fool
Masimo Corporation (MASI) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Masimo Corporation Securities Class Action
From Robbins LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hawaiian Electric, and Masimo and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Masimo Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - MASI
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
MASIMO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Masimo Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
MASIMO CORPORATION SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Masimo Corporation (NASDAQ: MASI)
From Bernstein Liebhard LLP
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From Law Offices of Howard G. Smith
Via Business Wire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Masimo Corporation (MASI) Investors
From Kirby McInerney LLP
Via Business Wire
MASI INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Masimo Corporation Investors with Substantial Losses Have Opportunity to Lead the Masimo Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Masimo Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MASI
From The Rosen Law Firm, P.A.
Via Business Wire
Shareholder Alert: Robbins LLP Informs Shareholders of Class Action Filed Against Masimo Corporation
From Robbins LLP
Via Business Wire
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
From Masimo
Via Business Wire
Masimo Reports Second Quarter 2023 Financial Results
From Masimo Corporation
Via Business Wire
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with Dexmedetomidine
From Masimo
Via Business Wire
Masimo, Medical Device Maker Drops on Q2 Guidance, Opportunity?
Shares of Masimo are at their lowest level since January 2019 — but according to Wall Street, could have healthy gains ahead. 
Via MarketBeat
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Masimo Corporation (MASI) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Nasdaq Futures Rise As Focus Turns To Tesla, Netflix Q2 Prints: Analyst Says Earnings Need Some 'Heavy Lifting' For Sustained Rally
 
Via Benzinga
Nasdaq Gains Over 100 Points; Lockheed Martin Profit Tops Expectations
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 100 points on Tuesday. The Dow traded up 1.09% to 34,961.65 while the NASDAQ rose 0.91% to 14,374.77.... 
Via Benzinga
Delay In Large Orders, Lower Inpatient Census To Ail Masimo's Q2 Results, Analyst Lowers Estimates
Needham analyst Mike Matson reiterated a Buy rating on Masimo Corporation (NASDAQ: MASI), lowering the  
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  During Tuesday's trading, 46 companies set new 52-week lows. 
Via Benzinga
Why Lixte Biotechnology Shares Are Trading Lower By 26%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) gained 90% to $0.3560 after the company issued strategic update and announced restructuring. 
Via Benzinga
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.